Apimeds Pharmaceuticals US, Inc. (AMEX:APUS) Financings

Apimeds Pharmaceuticals US, Inc.

Financings

RaiseDate
Private placement of pIPE financing
Closed: US$100M raised · E.F. Hutton & Co.
Dealers: E.F. Hutton & Co. (lead)
Use of proceeds: Ten percent of net proceeds to new subsidiary Newco, ninety percent to MindWave
May 5, 2026
Public offering of shares of common stock
Closed: US$13.5M raised · US$4 a share · D. Boral Capital LLC
Dealers: D. Boral Capital LLC (lead)
Use of proceeds: Phase III knee osteoarthritis trial, a multiple sclerosis sponsorship study, product manufacturing and general working capital
May 12, 2025

Read by 6ix AI from the company's releases